Literature DB >> 19819618

Upregulated fascin1 in non-small cell lung cancer promotes the migration and invasiveness, but not proliferation.

Jinbo Zhao1, Yongan Zhou, Zhipei Zhang, Feng Tian, Nan Ma, Tonggang Liu, Zhongping Gu, Yunjie Wang.   

Abstract

Fascin1, an actin-binding protein, is overexpressed in many kinds of tumors. However, its exact role in non-small cell lung cancer (NSCLC) is still unclear. We observed that expression of fascin1 was associated with lymph nodes metastasis and TNM staging but not proliferation in NSCLC by using immunohistochemistry. By generating A549 lung cancer clones stably overexpressing different fascin1 protein, we further confirmed that fascin1 could promote A549 cell migration and invasiveness in vitro and in vivo. Using cell proliferation assay, cell cycle analysis in vitro and tumorigenicity assay in vivo, we showed that fascin1 had little influence on proliferation in A549 cells. These results suggest that fascin1 plays a significant role in NSCLC metastasis and may be a target of intervening to prevent the metastasis of NSCLC. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819618     DOI: 10.1016/j.canlet.2009.09.013

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

1.  MicroRNA-133b inhibits the migration and invasion of non small cell lung cancer cells via targeting FSCN1.

Authors:  Xucheng Yang; Pengfei Lei; Yong Huang; Zijian Zhang; Yingying Zhang
Journal:  Oncol Lett       Date:  2016-08-25       Impact factor: 2.967

2.  Inhibiting CREPT reduces the proliferation and migration of non-small cell lung cancer cells by down-regulating cell cycle related protein.

Authors:  Tao Liu; Wei-Miao Li; Wu-Ping Wang; Ying Sun; Yun-Feng Ni; Hao Xing; Jing-Hua Xia; Xue-Jiao Wang; Zhi-Pei Zhang; Xiao-Fei Li
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

3.  Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.

Authors:  Zheng-sheng Wu; Chao-qun Wang; Ru Xiang; Xue Liu; Shan Ye; Xue-qing Yang; Gui-hong Zhang; Xiao-chun Xu; Tao Zhu; Qiang Wu
Journal:  BMC Cancer       Date:  2012-02-01       Impact factor: 4.430

4.  High ABCG4 Expression Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin-Based Chemotherapy.

Authors:  Guang Yang; Xue-Jiao Wang; Li-Jun Huang; Yong-An Zhou; Feng Tian; Jin-Bo Zhao; Peng Chen; Bo-Ya Liu; Miao-Miao Wen; Xiao-Fei Li; Zhi-Pei Zhang
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 5.  miR-206/133b Cluster: A Weapon against Lung Cancer?

Authors:  Jing-Yu Pan; Cheng-Cao Sun; Zhuo-Yue Bi; Zhen-Long Chen; Shu-Jun Li; Qing-Qun Li; Yu-Xuan Wang; Yong-Yi Bi; De-Jia Li
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-07       Impact factor: 8.886

Review 6.  Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis.

Authors:  Vanessa Y Tan; Sarah J Lewis; Josephine C Adams; Richard M Martin
Journal:  BMC Med       Date:  2013-02-26       Impact factor: 8.775

7.  Expression of Fascin-1 on human lung cancer and paracarcinoma tissue and its relation to clinicopathological characteristics in patients with lung cancer.

Authors:  Wei Zhao; Jing Gao; Jing Wu; Qiu-Hong Liu; Zhi-Gang Wang; Hui-Ling Li; Li-Hua Xing
Journal:  Onco Targets Ther       Date:  2015-09-15       Impact factor: 4.147

8.  TC-1 overexpression promotes cell proliferation in human non-small cell lung cancer that can be inhibited by PD173074.

Authors:  Jie Lei; Wenhai Li; Ye Yang; Qiang Lu; Na Zhang; Guangzhen Bai; Daixing Zhong; Kai Su; Boya Liu; Xiaofei Li; Yunjie Wang; Xiaoping Wang
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

9.  Fascin-1 as a novel diagnostic marker of triple-negative breast cancer.

Authors:  Chao-Qun Wang; Chih-Hsin Tang; Hao-Teng Chang; Xiao-Ni Li; Yong-Ming Zhao; Chen-Ming Su; Gui-Nv Hu; Tao Zhang; Xin-Xin Sun; Yue Zeng; Zhang Du; Yan Wang; Bi-Fei Huang
Journal:  Cancer Med       Date:  2016-05-17       Impact factor: 4.452

10.  FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer.

Authors:  Chao-Qun Wang; Chih-Hsin Tang; Yan Wang; Lulu Jin; Qian Wang; Xiaoni Li; Gui-Nv Hu; Bi-Fei Huang; Yong-Ming Zhao; Chen-Ming Su
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.